Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-23-035920
Filing Date
2023-02-13
Accepted
2023-02-13 16:33:00
Documents
2
Group Members
CHANG 2006 FAMILY TRUSTJEC 2019 TRUSTRTC 2019 TRUST

Document Format Files

Seq Description Document Type Size
1 SC 13G d411988dsc13g.htm SC 13G 87881
2 EX-99.1 d411988dex991.htm EX-99.1 5456
  Complete submission text file 0001193125-23-035920.txt   94709
Mailing Address C/O ALLOGENE THERAPEUTICS, INC. 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Chang David D (Filed by) CIK: 0001611024 (see all company filings)

Type: SC 13G

Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Subject) CIK: 0001737287 (see all company filings)

EIN.: 823562771 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90685 | Film No.: 23619058
SIC: 2836 Biological Products, (No Diagnostic Substances)